Characterization of T cell receptor associated with the development of P2 peptide-induced autoimmune neuritis

Citation
Y. Matsumoto et al., Characterization of T cell receptor associated with the development of P2 peptide-induced autoimmune neuritis, J NEUROIMM, 102(1), 2000, pp. 67-72
Citations number
21
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROIMMUNOLOGY
ISSN journal
01655728 → ACNP
Volume
102
Issue
1
Year of publication
2000
Pages
67 - 72
Database
ISI
SICI code
0165-5728(20000103)102:1<67:COTCRA>2.0.ZU;2-3
Abstract
To characterize experimental autoimmune neuritis (EAN)-inducing T cells in more detail, we performed CDR3 spectratyping analysis and found oligoclonal expansion of several V beta spectratypes in nerve-infiltrating T cells. V beta 5 expansion was observed all the stages examined, whereas V beta 8.2 a nd V beta 17 expansion was mainly found at the peak and preclinical stages, respectively. Since V beta 5 expansion persists throughout the course of t he disease, V beta 5(+) T cells are judged to be the main effector cells. V beta 8.2(+) and V beta 17(+) T cells may also be pathogenic but are not th e main effecters because expansion of these spectratypes was found at a lim ited period of time. Sequence analysis revealed that V beta 5, V beta 8.2 a nd V beta 17 spectratype-derived TCR clones possess their own dominant sequ ences in the CDR3 region with no homology among the clones. These findings suggest that polyclonally activated T cells are involved in the formation o f the nerve lesion. Furthermore, vaccination with V beta 5 DNA, but not wit h V beta 10 DNA, suppressed the development of EAN significantly. Collectiv ely, these findings indicate that determination of autoimmune disease-assoc iated TCR by CDR3 spectratyping provides useful information for designing T CR-based immunotherapy for the disease. (C) 2000 Elsevier Science B.V. All rights reserved.